Gold Coast haematology services manage severe aplastic anaemia and refractory ITP patients requiring higher-dose Eltrombopag therapy. Rompag 50mg provides substantial cost savings compared to brand Revolade for Queensland patients.
Clinical evidence supports combination Eltrombopag therapy producing high response rates in aplastic anaemia patients undergoing standard immunosuppressive treatment protocols.
|
FAQ: What ongoing monitoring is required for Gold Coast
patients on long-term Rompag therapy? Long-term monitoring
includes regular full blood counts to track platelet, red cell, and white
cell response, periodic liver function tests, and clinical assessment for any
signs of fibrosis in the bone marrow (a rare but recognised long-term risk
with extended TPO-RA use). Your haematologist will establish an appropriate
monitoring schedule based on your treatment duration and response. |
